Measurement of Intratumor Heterogeneity and Its Changing Pattern to Predict Response and Recurrence Risk After

Mingxi Zhu1, Qiong Wu1, Xiaochuan Geng2

  • 1Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

PubMed
Summary

Tumor heterogeneity quantified by magnetic resonance imaging (MRI) can predict treatment response in breast cancer patients receiving neoadjuvant chemotherapy (NAC). Lower heterogeneity indicates a better pathological complete response (pCR), aiding precision medicine approaches.